This page
linked at "Slump in Oil Price 2014 - 2016" at the sidebar.
Pending.
The conference calls that will perhaps be most interesting to help understand the Bakken this past year (2015) and the coming year (2016). This list is not yet complete.
Ticker symbol, analysts' forecast for quarterly earnings, earnings release date (conference call usually occurs same day or next morning). Dates are subject to change, and often do change.
CLR:
a loss of 14 cents/share, February 22, 2016
COP (BR):
a loss of 41 cents/share, January 27, 2016
ENB: May 6, 2016, hopefully we will have some information earlier
EOG:
a loss of 21 cents/share, February 25, 2016
MRO:
a loss of 43 cents/share, February 16, 2016
Oneok: OKS,
a profit of 51 cents/share; OKE,
a profit of 45 cents/share; February 22, 2016
TSO:
a profit of $2.20/share; February 9, 2016
WLL:
a loss of 23 cents/share; February 23, 2016
XOM:
a profit of 72 cents/share; February 2,2016
This is not an investment site. Do not make any investment or financial decisions based on what you read here or think you may have read here. The conference calls should provide some insight into where the Bakken was last year and where it will be going this year.
**************************
Speaking of Profits: Amazon
From Wired, July 23, 2015:
Amazon made
a $92 million profit last quarter, or about 19 cents per share. That’s
peanuts compared to other tech giants like Google, which netted $3.93
billion last quarter, or eBay, which made $682 million. But analysts
expected Amazon to lose 14 cents per share. In fact, it’s
unusual that Amazon, a 21-year-old company, actually turns a profit at
all. Last year the company lost 27 cents a share in the second quarter.
From lbtimes, December 18, 2013:
Amazon: Nearly 20 Years In Business And It Still Doesn't Make Money, But Investors Don't Seem To Care
********************************
Blind Spots
When it comes to immigration, it's "open borders." But when it come to taxes and corporations, all of a sudden, Congress, Clinton, Obama, and Trump want closed borders. All are against "inversions."
The New Yorker in the most recent issue, "The biggest corporate deal of 2015 was also, in the view of many, the shadiest: Pfizer's $160-billion merger with the Irish drug company Allergan."
The writer noted this about Pfizer: "Look at Pfizer. The CEO was born in Scotland and raised in Rhodesia. More than sixty per cent of its revenue comes from overseae, and most of its employees work abroad."
The big question: so why is Pfizer an American company? Whatever.
By the way Pfizer's CEO was born in Scotland raised in Rhodesia. Our own president was born in Hawaii and everything he learned before kindergarten was in Indonesia. LOL.